---
title: "Solesence | 8-K: FY2026 Q1 Revenue: USD 12.96 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286097612.md"
datetime: "2026-05-12T12:17:08.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286097612.md)
  - [en](https://longbridge.com/en/news/286097612.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286097612.md)
---

# Solesence | 8-K: FY2026 Q1 Revenue: USD 12.96 M

Revenue: As of FY2026 Q1, the actual value is USD 12.96 M.

EPS: As of FY2026 Q1, the actual value is USD -0.01.

EBIT: As of FY2026 Q1, the actual value is USD -241 K.

Solesence, Inc. reported its financial results for the first quarter ended March 31, 2026, emphasizing operational excellence and new technology commercialization under its Transform and Transcend strategic initiative .

#### Revenue

-   Net revenue for the first quarter of 2026 was $12,957 thousand, decreasing from $14,625 thousand for the same period in 2025 .
-   Product revenue was $12,919 thousand in Q1 2026, compared to $14,575 thousand in Q1 2025 .
-   Other revenue was $38 thousand in Q1 2026, down from $50 thousand in Q1 2025 .

#### Gross Profit and Margin

-   Gross profit in Q1 2026 was $3,337 thousand, a slight decrease from $3,382 thousand in Q1 2025 .
-   Gross margin improved to 26% in Q1 2026, up from 23% in Q1 2025 .
-   Cost of revenue was $9,620 thousand in Q1 2026, compared to $11,243 thousand in Q1 2025 .

#### Operating Expenses

-   Research and development expense was $1,042 thousand in Q1 2026, compared to $1,018 thousand in Q1 2025 .
-   Selling, general and administrative expense increased to $2,799 thousand in Q1 2026, from $2,108 thousand in Q1 2025 .

#### Profitability

-   Net loss from operations was -$504 thousand in Q1 2026, a decline from net income from operations of $256 thousand in Q1 2025 .
-   Net loss for Q1 2026 was -$766 thousand, compared to net income of $80 thousand for Q1 2025 .
-   Net loss per share-basic was -$0.01 in Q1 2026, compared to $0.00 in Q1 2025 .
-   Adjusted EBITDA (Non-GAAP) was -$107 thousand in Q1 2026, down from $609 thousand in Q1 2025 .

#### Balance Sheet Highlights

-   Cash decreased to $573 thousand as of March 31, 2026, from $1,288 thousand as of December 31, 2025 .
-   Trade accounts receivable, net, was $6,379 thousand as of March 31, 2026, compared to $6,836 thousand as of December 31, 2025 .
-   Inventories, net, stood at $17,559 thousand as of March 31, 2026, down from $18,511 thousand as of December 31, 2025 .
-   Total current assets were $26,413 thousand as of March 31, 2026, decreasing from $28,776 thousand as of December 31, 2025 .
-   Total assets were $47,794 thousand as of March 31, 2026, compared to $50,055 thousand as of December 31, 2025 .
-   Total current liabilities were $12,691 thousand as of March 31, 2026, a decrease from $13,929 thousand as of December 31, 2025 .
-   Accumulated deficit was -$99,404 thousand as of March 31, 2026, compared to -$98,638 thousand as of December 31, 2025 .

#### Outlook / Guidance

Solesence, Inc. expects its investments in operational infrastructure, including employee training and organizational restructuring, to position the company for improved operational and financial results through the year . The company is also focused on leveraging its intellectual property, expanding its addressable market, and evolving its service model to drive long-term, sustainable profitability and growth .

### Related Stocks

- [SLSN.US](https://longbridge.com/en/quote/SLSN.US.md)

## Related News & Research

- [Why FormFactor stock is skyrocketing today](https://longbridge.com/en/news/294397637.md)
- [Teleperformance publishes H1 2026 interim financial report for period ended June 30](https://longbridge.com/en/news/294393962.md)
- [FreeCast files Form 3 initial beneficial ownership statement for director Eric William John Seidel](https://longbridge.com/en/news/294238285.md)
- [California Bancorp Q2 profit rises, dividend to increase](https://longbridge.com/en/news/293930008.md)
- [Dynatrace files Form 3 initial beneficial ownership statement for director Thota Chandrasekhar](https://longbridge.com/en/news/294255264.md)